<DOC>
	<DOCNO>NCT02174211</DOCNO>
	<brief_summary>To study effect par plana vitrectomy posterior vitreous detachment intravitreal pharmacokinetics ranibizumab</brief_summary>
	<brief_title>Effect Vitrectomy Posterior Vitreous Detachment Intravitreal Ranibizumab Pharmacokinetics</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Vitreous Detachment</mesh_term>
	<mesh_term>Ranibizumab</mesh_term>
	<criteria>Adults either sex age 55 year older Active neovascular AMD study eye Intravitreal dose 0.5 mg ranibizumab require , per current clinical guideline Venous access sufficient allow easy blood sample frequent basis Able give write consent Willingness comply study procedure Myopia great 8 dioptre study eye Axial length eye 22mm 26mm Pseudophakia aphakia study eye Glaucoma study eye Current renal dialysis Presence inflammatory eye condition , uveitis , systemic condition likely elevate CRP , infection , rheumatoid arthritis , vasculitis , asthma inflammatory bowel disease . Intraocular surgery within 6 month enrolment , except routine phacoemulsification cataract surgery may occur within 4 month enrolment Current treatment wet agerelated macular degeneration intravitreal agent ranibizumab study eye . Patients expect change antiVEGF agent sample period also exclude . Known significant allergy ranibizumab Participants , opinion Investigator , would willing able comply study protocol provide inform consent . Patients severe anaemia Patients receive antiVEGF therapy either eye within 8 week enrolment , likely require antiVEGF treatment fellow eye course venous sample . Note final venous sample 4 week undertaken day antiVEGF injection , must take prior injection . Patients presently take topical ( skin eye ) , periocular , intraocular , local systemic treatment immunosuppressive antiinflammatory agent , steroid , steroid spar agent , NSAIDs . Patients receive agent within 2 month prior enrolment also exclude , think likely receive medication course venous sampling .</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>